Synthesis Strategies and Biomedical Applications of Chiral Metal Clusters: A Recent Research Progress
Аннотация
ABSTRACT Chiral metal clusters (CMCs) integrate atomically precise structures with molecule‐like electronic transitions, enabling the direct mapping of atomic‐scale stereochemistry onto biological recognition. However, the quantitative relationships among cluster hierarchy (core, interface, and ligand), chiroptical intensity, and enantioselective bioactivity remain elusive. Unlike conventional chiral nanomaterials, metal clusters provide an ideal platform for understanding the relationship between atomic‐scale chirality and biological functions due to their precisely determined compositions and hierarchical structural features. In this review, we summarize recent advances in the synthesis strategies, chirality origins, and biomedical applications of CMCs. The major approaches for constructing CMCs, including chiral ligand induction, chiral template/environment‐assisted synthesis, spontaneous resolution, and postsynthetic functionalization, are systematically discussed. Furthermore, the structural origins of chirality arising from metal cores, metal–ligand interfaces, and ligand shells, as well as their regulation mechanisms, are highlighted. Recent biomedical applications of CMCs in biosensing, bioimaging, antibacterial therapy, and anticancer treatment are comprehensively reviewed, with emphasis on chirality‐dependent biological interactions and functional regulation. Finally, current challenges, including quantitative structure–property–activity relationships, physiological stability, in vivo behaviors, and clinical translation, are discussed. Future perspectives focusing on rational design, multifunctional theragnostic platforms, biomolecular hybrid systems, and scalable synthesis are proposed. This review provides insights into the development of CMCs as advanced platforms for precision biomedical applications.